Bupropion-SR for smoking reduction and cessation in alcohol-dependent outpatients: A naturalistic, open-label study

Current Clinical Pharmacology

Volumn 9, Issue 2, 2014, Pages 123-129

  Karam Hage, Maher ^a   Robinson, Jason D ^a   Lodhi, Ashutosh ^a   Brower, Kirk J ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Alcohol dependence; Bupropion; Cessation; Nicotine; Smoking; Treatment

Indexed keywords

AMFEBUTAMONE; DELAYED RELEASE FORMULATION;

ABSTINENCE; ADULT; ALCOHOL ABSTINENCE; ALCOHOLISM; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; NATURALISTIC INQUIRY; OPEN STUDY; OUTPATIENT; PRIORITY JOURNAL; SMOKING; SMOKING CESSATION; SMOKING CESSATION PROGRAM; SMOKING REGULATION; SUSTAINED DRUG RELEASE; TOBACCO; XEROSTOMIA; CASE CONTROL STUDY; CLINICAL TRIAL; DELAYED RELEASE FORMULATION; MIDDLE AGED; PREVENTION AND CONTROL; PROCEDURES; TIME; TOBACCO USE DISORDER; TREATMENT OUTCOME;

ADULT; ALCOHOL ABSTINENCE; BUPROPION; CASE-CONTROL STUDIES; DELAYED-ACTION PREPARATIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OUTPATIENTS; SMOKING; SMOKING CESSATION; TIME FACTORS; TOBACCO USE DISORDER; TREATMENT OUTCOME;

EID: 84921425063     PISSN: 15748847     EISSN: None     Source Type: Journal    
DOI: 10.2174/1574884708666131112124429     Document Type: Article

References (39)

1. Breslau N, Peterson E, Schultz L, Andreski P, Chilcoat H. Are smokers with alcohol disorders less likely to quit? Am J Public Health 1996; 86: 985-90.
2. Hughes JR, Kalman D. Do smokers with alcohol problems have more difficulty quitting? Drug Alcohol Depend 2006; 82: 91-102.
3. Batel P, Pessione F, Maitre C, Rueff B. Relationship between alcohol and tobacco dependencies among alcoholics who smoke. Addiction 1995; 90: 977-80.
4. John U, Meyer C, Rumpf HJ, Schumann A, Thyrian JR, Hapke U. Strength of the relationship between tobacco smoking, nicotine dependence and the severity of alcohol dependence syndrome criteria in a population-based sample. Alcohol Alcohol 2003; 38: 606-12.
5. Hart CL, Davey SG, Gruer L, Watt GC. The combined effect of smoking tobacco and drinking alcohol on cause-specific mortality: a 30 year cohort study. BMC Public Health 2010; 10: 789.
6. Littleton J, Barron S, Prendergast M, Nixon SJ. Smoking kills [alcoholics]! Shouldn't we do something about it? Alcohol Alcohol 2007; 42: 167-73.
7. Samet JM. Smoking kills: experimental proof from the Lung Health Study. Ann Intern Med 2005; 142: 299-301.
8. Xu WH, Zhang XL, Gao YT, et al. Joint effect of cigarette smoking and alcohol consumption on mortality. Prev Med 2007; 45: 313-9.
9. Ellingstad TP, Sobell LC, Sobell MB, Cleland PA, Agrawal S. Alcohol abusers who want to quit smoking: Implications for clinical treatment. Drug Alcohol Depend 1999; 54: 259-65.
10. Hurt RD, Offord KP, Croghan IT, et al. Mortality following inpatient addictions treatment: Role of tobacco use in a community-based cohort. JAMA 1996; 275: 1097-103.
11. Bobo JK, McIlvain HE, Lando HA, Walker RD, Leed-Kelly A. Effect of smoking cessation counseling on recovery from alcoholism: Findings from a randomized community intervention trial. Addiction 1998; 93: 877-87.
12. Hintz T, Mann K. Long-term behavior in treated alcoholism: Evidence for beneficial carry-over effects of abstinence from smoking on alcohol use and vice versa. Addict Behav 2007; 32: 3093-100.
13. Stead LF, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2008; 1: CD000146.
14. Hays JT, Schroeder DR, Offord KP, et al. Response to nicotine dependence treatment in smokers with current and past alcohol problems. Ann Behav Med 1999; 21: 244-50.
15. Hurt RD, Sachs DP, Glover ED, et al. A comparison of sustainedrelease bupropion and placebo for smoking cessation. N Engl J Med 1997; 337: 1195-202.
16. Jorenby DE, Leischow SJ, Nides MA, et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 1999; 340: 685-91.
17. Piper ME, Smith SS, Schlam TR, et al. A randomized placebocontrolled clinical trial of 5 smoking cessation pharmacotherapies. Arch Gen Psychiatry 2009; 66: 1253-62.
18. Smith SS, McCarthy DE, Japuntich SJ, et al. Comparative effectiveness of 5 smoking cessation pharmacotherapies in primary care clinics. Arch Intern Med 2009; 169: 2148-55.
19. Hayford KE, Patten CA, Rummans TA, et al. Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism. Br J Psychiatry 1999; 174: 173-8.
20. Leeman RF, McKee SA, Toll BA, et al. Risk factors for treatment failure in smokers: Relationship to alcohol use and to lifetime history of an alcohol use disorder. Nicotine Tob Res 2008; 10: 1793-809.
21. Aubin HJ. Tolerability and safety of sustained-release bupropion in the management of smoking cessation. Drugs 2002; 62(Suppl 2): 45-52.
22. Grant KM, Kelley SS, Smith LM, Agrawal S, Meyer JR, Romberger DJ. Bupropion and nicotine patch as smoking cessation aids in alcoholics. Alcohol 2007; 41: 381-91.
23. Prochaska JJ. Smoking and mental illness--breaking the link. N Engl J Med 2011; 365: 196-8.
24. Gratzer D, Levitan RD, Sheldon T, Toneatto T, Rector NA, Goering P. Lifetime rates of alcoholism in adults with anxiety, depression, or co-morbid depression/anxiety: a community survey of Ontario. J Affect Disord 2004; 79: 209-15.
25. Sher L. Depression and alcoholism. QJM 2004; 97: 237-40.
26. US Food and Drug Administration. Postmarketing Review: The smoking cessation aids varenicline and bupropion. Suicidal ideation and behavior. Drug Safety Newsletter 2009 (cited 2011 May 31); 2(1)Available from: URL: http://www.fda.gov/downloads/Drugs/ DrugSafety/DrugSafetyNewsletter/UCM107318.pdf
27. Karam-Hage M, Pomerleau CS, Pomerleau OF, Brower KJ. Unaided smoking cessation among smokers in treatment for alcohol dependence. Addict Behav 2005; 30: 1247-53.
28. Benowitz NL, Ahijevych K, Hall S, et al. Biochemical verification of tobacco use and cessation. Nicotine Tob Res 2002; 4: 149-59.
29. Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev 2007; 1: CD000031.
30. PDR staff. Physicians' desk reference [65th ed.]. Montvale, NJ: Thomson PDR; 2011.
31. Hatsukami DK, Rennard S, Patel MK, et al. Effects of sustainedrelease bupropion among persons interested in reducing but not quitting smoking. Am J Med 2004; 116: 151-7.
32. Fiore MC, Jaen CR, Baker TB, et al. Treating Tobacco Use and Dependence: 2008 Update, Clinical Practice Guideline. Rockville, MD: U. S. Department of Health and Human Services. Public Health Service; 2008.
33. Larsson A, Engel JA. Neurochemical and behavioral studies on ethanol and nicotine interactions. Neurosci Biobehav Rev 2004; 27: 713-20.
34. Tsoh JY, Chi FW, Mertens JR, Weisner CM. Stopping smoking during first year of substance use treatment predicted 9-year alcohol and drug treatment outcomes. Drug Alcohol Depend 2011; 114: 110-8.
35. Donovan DM, Floyd AS. Facilitating involvement in twelve-step programs. Recent Dev Alcohol 2008; 18: 303-20.
36. Emrick CD, Tonigan JS, Montgomery H, Little L. Alcoholics Anonymous: What is currently known? In: McCrady BS, Miller WR, editors. Research on Alcoholics Anonymous: Opportunities and alternatives. Piscataway, NJ: Rutgers Center of Alcohol Studies; 1993. p. 41-76.4
37. Tonigan JS, Toscova R, Miller WR. Meta-analysis of the literature on Alcoholics Anonymous: Sample and study characteristics moderate findings. J Stud Alcohol 1996; 57: 65-72.
38. Tonigan JS. Alcoholics anonymous outcomes and benefits. Recent Dev Alcohol 2008; 18: 357-72.
39. Maisto SA, Sobell LC, Sobell MB. Corroboration of drug abusers' self-reports through the use of multiple data sources. Am J Drug Alcohol Abuse 1982; 9: 301-8.